HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 615 | 755 | 81.5% | |
| HF 4 | 2012 | 588 | 726 | 81.0% | |
| HF 4 | 2013 | 604 | 716 | 84.4% | |
| HF004 | 2014 | 306 | 330 | 92.7% | |
| HF004 | 2015 | 349 | 374 | 93.3% | |
| HF004 | 2016 | 375 | 397 | 94.5% | |
| HF004 | 2017 | 436 | 462 | 94.4% | |
| HF004 | 2018 | 495 | 521 | 95.0% | |
| HF004 | 2019 | 616 | 651 | 94.6% | |
| HF004 | 2020 | 742 | 790 | 93.9% | |
| HF006 | 2021 | 1123 | 1261 | 89.1% | |
| HF006 | 2022 | 1431 | 1539 | 93.0% | |
| HF006 | 2023 | 1633 | 1669 | 97.8% |
